Long-Term Follow Up of Patients with Chronic HCV and No or Minimal Fibrosis Shows Low Risk for Liver-Related Morbidity and Mortality After Achieving SVR with DAA-Based Therapy: Results from the Gilead SVR Registry
Journal article published in 2017 by
Marc Bourliere,
Edward J. Gane,
Ira Jacobson,
Stuart C. Gordon,
Mark S. Sulkowski,
Brian L. McNabb,
Frances Chen,
Hadas Dvory-Sobol,
John McNally,
Diana M. Brainard,
Mani Subramanian,
Alnoor Ramji,
Stefan Zeuzem,
Kosh Agarwal 
,
K. Rajender Reddy
,
K. Rajender Reddy
